What is the recommended dose of Amoxicillin/Clavulanate (Amoxclav) tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Amoxicillin/Clavulanate (Amoxclav) Tablets

The recommended adult dose of amoxicillin/clavulanate (Amoxclav) tablets is 875 mg/125 mg twice daily or 500 mg/125 mg three times daily for standard infections, with high-dose formulations of 2000 mg/125 mg twice daily available for more severe respiratory infections or resistant pathogens. 1, 2

Adult Dosing Recommendations

Standard Dosing

  • Regular strength:
    • 875/125 mg twice daily OR
    • 500/125 mg three times daily 1
  • Duration: 5-7 days for most respiratory infections in adults 2

High-Dose Formulations

  • Enhanced formulation: 2000/125 mg twice daily (Augmentin XR) for:
    • Respiratory infections with suspected drug-resistant pathogens
    • Streptococcus pneumoniae with reduced penicillin susceptibility 3, 4

Pediatric Dosing Recommendations

  • Standard dosing: 45 mg/kg/day of amoxicillin component in divided doses every 12 hours 2
  • High-dose formulation: 90 mg/kg/day of amoxicillin component in two divided doses (Augmentin ES-600) 3
  • Duration: 10-14 days recommended for children 2

Dosing Based on Infection Type

Respiratory Tract Infections

  • Mild/Moderate: 875 mg every 12 hours or 500 mg every 8 hours 1
  • Severe: 875 mg every 12 hours or 500 mg every 8 hours 1

Skin/Skin Structure Infections

  • Mild/Moderate: 500 mg every 12 hours or 250 mg every 8 hours 1
  • Severe: 875 mg every 12 hours or 500 mg every 8 hours 1

Dosing in Special Populations

Renal Impairment

  • GFR 10-30 mL/min: 500 mg or 250 mg every 12 hours (depending on infection severity)
  • GFR <10 mL/min: 500 mg or 250 mg every 24 hours (depending on infection severity)
  • Hemodialysis: 500 mg or 250 mg every 24 hours plus additional dose during and after dialysis 1
  • Note: Patients with GFR <30 mL/min should NOT receive the 875 mg dose 1

Clinical Considerations

  • Take at the start of a meal to minimize gastrointestinal intolerance 1
  • For S. pyogenes (Group A Streptococcus) infections, treatment should continue for at least 10 days to prevent acute rheumatic fever 1
  • The pharmacokinetically enhanced formulation (2000/125 mg) maintains plasma amoxicillin concentrations above 4 μg/mL for approximately 49% of the dosing interval, making it effective against S. pneumoniae with higher MICs 4
  • Clinical studies have shown that a 5-day course of high-dose amoxicillin-clavulanate (2000/125 mg) is as effective as a 7-day course of conventional dosing (875/125 mg) for acute exacerbations of chronic bronchitis 5

Common Pitfalls to Avoid

  • Do not confuse the pediatric high-dose formulation (90 mg/kg/day) with standard dosing (45 mg/kg/day) 3
  • The 250 mg and 500 mg tablets contain the same amount of clavulanic acid (125 mg), so two 250 mg tablets are not equivalent to one 500 mg tablet 2
  • Ensure complete course of therapy is taken, even if symptoms improve before completion
  • For patients with penicillin allergy, alternative antibiotics should be considered rather than amoxicillin/clavulanate 6

Amoxicillin/clavulanate remains a cornerstone antibiotic for community-acquired infections, with various formulations designed to address the growing concern of antimicrobial resistance while maintaining excellent clinical efficacy 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.